Anchor Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.1K | Hold |
1,203
| – | – | 0.01% | 511 |
|
|
2025
Q1 | $88.4K | Hold |
1,203
| – | – | 0.01% | 482 |
|
|
2024
Q4 | $78.8K | Sell |
1,203
-76
| -6% | -$4.98K | 0.01% | 505 |
|
|
2024
Q3 | $99.6K | Buy |
1,279
+893
| +231% | +$69.6K | 0.01% | 463 |
|
|
2024
Q2 | $30.1K | Hold |
386
| – | – | ﹤0.01% | 586 |
|
|
2024
Q1 | $26.2K | Hold |
386
| – | – | ﹤0.01% | 631 |
|
|
2023
Q4 | $26K | Hold |
386
| – | – | ﹤0.01% | 617 |
|
|
2023
Q3 | $26.1K | Hold |
386
| – | – | ﹤0.01% | 617 |
|
|
2023
Q2 | $27.6K | Hold |
386
| – | – | ﹤0.01% | 602 |
|
|
2023
Q1 | $26.8K | Hold |
386
| – | – | ﹤0.01% | 619 |
|
|
2022
Q4 | $26.2K | Sell |
386
-3
| -0.8% | -$203 | ﹤0.01% | 607 |
|
|
2022
Q3 | $21.3K | Hold |
389
| – | – | ﹤0.01% | 621 |
|
|
2022
Q2 | $25.7K | Hold |
389
| – | – | ﹤0.01% | 614 |
|
|
2022
Q1 | $25.8K | Hold |
389
| – | – | ﹤0.01% | 630 |
|
|
2021
Q4 | $22.7K | Hold |
389
| – | – | ﹤0.01% | 678 |
|
|
2021
Q3 | $23.4K | Hold |
389
| – | – | ﹤0.01% | 625 |
|
|
2021
Q2 | $23.3K | Hold |
389
| – | – | ﹤0.01% | 639 |
|
|
2021
Q1 | $19.3K | Buy |
389
+3
| +0.8% | +$149 | ﹤0.01% | 631 |
|
|
2020
Q4 | $19.3K | Hold |
386
| – | – | ﹤0.01% | 601 |
|
|
2020
Q3 | $21.2K | Hold |
386
| – | – | ﹤0.01% | 556 |
|
|
2020
Q2 | $20.4K | Hold |
386
| – | – | ﹤0.01% | 552 |
|
|
2020
Q1 | $17.2K | Buy |
386
+35
| +10% | +$1.56K | ﹤0.01% | 556 |
|
|
2019
Q4 | $17.5K | Hold |
351
| – | – | ﹤0.01% | 583 |
|
|
2019
Q3 | $15.6K | Hold |
351
| – | – | ﹤0.01% | 594 |
|
|
2019
Q2 | $14.5K | Hold |
351
| – | – | ﹤0.01% | 601 |
|
|
2019
Q1 | $14.2K | Hold |
351
| – | – | ﹤0.01% | 597 |
|
|
2018
Q4 | $13.3K | Hold |
351
| – | – | ﹤0.01% | 593 |
|
|
2018
Q3 | $13.9K | Hold |
351
| – | – | ﹤0.01% | 613 |
|
|
2018
Q2 | $12.3K | Buy |
+351
| New | +$12.3K | ﹤0.01% | 633 |
|